These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 23010482)
21. Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures. Eke I; Cordes N Radiother Oncol; 2011 Jun; 99(3):279-86. PubMed ID: 21704406 [TBL] [Abstract][Full Text] [Related]
22. Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib. Serrels A; Macpherson IR; Evans TR; Lee FY; Clark EA; Sansom OJ; Ashton GH; Frame MC; Brunton VG Mol Cancer Ther; 2006 Dec; 5(12):3014-22. PubMed ID: 17148760 [TBL] [Abstract][Full Text] [Related]
23. Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage. Wie SM; Adwan TS; DeGregori J; Anderson SM; Reyland ME J Biol Chem; 2014 Apr; 289(15):10900-10908. PubMed ID: 24569990 [TBL] [Abstract][Full Text] [Related]
24. Target modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targeting. Rao S; Larroque-Lombard AL; Peyrard L; Thauvin C; Rachid Z; Williams C; Jean-Claude BJ PLoS One; 2015; 10(2):e0117215. PubMed ID: 25658745 [TBL] [Abstract][Full Text] [Related]
25. EGFR-inhibition enhances apoptosis in irradiated human head and neck xenograft tumors independent of effects on DNA repair. Stegeman H; Span PN; Cockx SC; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH; Bussink J Radiat Res; 2013 Oct; 180(4):414-21. PubMed ID: 24059677 [TBL] [Abstract][Full Text] [Related]
26. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia. Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123 [TBL] [Abstract][Full Text] [Related]
27. The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells. Storch K; Cordes N Int J Oncol; 2016 Jan; 48(1):191-8. PubMed ID: 26573875 [TBL] [Abstract][Full Text] [Related]
28. Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests. Kriegs M; Kasten-Pisula U; Riepen B; Hoffer K; Struve N; Myllynen L; Braig F; Binder M; Rieckmann T; Grénman R; Petersen C; Dikomey E; Rothkamm K Oncotarget; 2016 Jul; 7(29):45122-45133. PubMed ID: 27281611 [TBL] [Abstract][Full Text] [Related]
29. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072 [TBL] [Abstract][Full Text] [Related]
30. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells. Nautiyal J; Yu Y; Aboukameel A; Kanwar SS; Das JK; Du J; Patel BB; Sarkar FH; Rishi AK; Mohammad RM; Majumdar AP Mol Cancer Ther; 2010 Jun; 9(6):1503-14. PubMed ID: 20515951 [TBL] [Abstract][Full Text] [Related]
31. Targeted Therapies in HPV-positive and -negative HNSCC - Alteration of EGFR and VEGFR-2 Expression In Vitro. Kramer B; Hock C; Birk R; Sauter A; Stuck BA; Hörmann K; Schultz JD; Aderhold C Anticancer Res; 2016 Jun; 36(6):2799-807. PubMed ID: 27272791 [TBL] [Abstract][Full Text] [Related]
32. Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop. Hayes KE; Walk EL; Ammer AG; Kelley LC; Martin KH; Weed SA Oncogene; 2013 Oct; 32(40):4766-77. PubMed ID: 23146907 [TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab. Wheeler DL; Iida M; Kruser TJ; Nechrebecki MM; Dunn EF; Armstrong EA; Huang S; Harari PM Cancer Biol Ther; 2009 Apr; 8(8):696-703. PubMed ID: 19276677 [TBL] [Abstract][Full Text] [Related]
34. Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis. Nagaraj NS; Smith JJ; Revetta F; Washington MK; Merchant NB Mol Cancer Ther; 2010 Aug; 9(8):2322-32. PubMed ID: 20682659 [TBL] [Abstract][Full Text] [Related]
35. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma. Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738 [TBL] [Abstract][Full Text] [Related]
36. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377 [TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells. Chang AY; Wang M BMC Cancer; 2013 May; 13():267. PubMed ID: 23721490 [TBL] [Abstract][Full Text] [Related]
38. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438 [TBL] [Abstract][Full Text] [Related]
39. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Harari PM; Huang SM Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):427-33. PubMed ID: 11173137 [TBL] [Abstract][Full Text] [Related]
40. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Dittmann K; Mayer C; Kehlbach R; Rodemann HP Mol Cancer; 2008 Sep; 7():69. PubMed ID: 18789131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]